Carl Cirino
Orthopaedic Surgery · New York, NYNPI 1538693858
Payments from drug & device makers
Across 58 payments — averaging $293.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Stryker$3K
- Encore Medical, LP$1K
- Polaris Technology Solutions LLC$761
- Exactech, Inc.$576
- Smith+Nephew$468
- plus $1K from 5 others
What the payments were for
- Grants$10,00059%
- Travel & lodging$2,80016%
- Food & beverage$3,89923%
- Education$3412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $10,000 |
| Stryker | 33 | $3,188 |
| Encore Medical, LP | 5 | $1,009 |
| Polaris Technology Solutions LLC | 3 | $761 |
| Exactech, Inc. | 4 | $576 |
| Smith+Nephew | 7 | $468 |
| Medtronic | 1 | $341 |
| Osteoremedies, LLC | 1 | $194 |
| Suvon Surgical LLC | 1 | $171 |
| Catalyst Orthoscience | 1 | $168 |
| Globus Medical | 1 | $162 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,911
- DJO SURGICAL$1,835
- EQUINOXE$576
- Bone Anchors with Arthroscopic Delivery System$254
- BIOWASH Surgical Irrigation$194
- OsteoBoost Select 5cc$194
- Remedy Spacer$194
- Remedy Spectrum GV Spacer$194
- BioBrush$194
- EXACTECHGPS$177
- AEQUALIS PERFORM$172
- HIPCHECK$172
- CSR & R1 Reverse Total Shoulder Systems$168
- R1 Reverse Total Shoulder$168
- Archer 3D Software$168
- PANGEA$152
- AXSOS$140
- GAMMA$120
How this compares
$17,040 in reported general payments places this provider in the 70th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 14 | $128 |
| Methylprednisolone | 14 | $78 |
| Gabapentin | 11 | $43 |
| Meloxicam | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$27M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$14.1M
- William RicciNew York$11.6M
- Steven HaasNew York$11.5M
- Giles ScuderiNew York$10.9M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.